← All organizations

Translational Research in Oncology

Academic/HospitalWebsite ↗

Also known as: Translational Research in Oncology | Translational Research in Oncology-U.S

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 4, 2023

Timeline

1990s

Jan 1, 1997
Translational Research in Oncology— Founded

Drugs by trial phase (25 distinct, 21 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (13 own, 0 via acquisition)

Phase 1 (9 own, 0 via acquisition)

Indications

Studied for

Recent trials (23)

NCT06005740CollaboratorPhase 1Dec 4, 2023
NCT05948826CollaboratorPhase 1Sep 29, 2023
NCT05582031Lead sponsorPhase 2Jan 31, 2023
NCT05156866CollaboratorPhase 1Jan 15, 2022
NCT05103046CollaboratorPhase 1Dec 15, 2021
NCT04777851Lead sponsorPhase 3Dec 15, 2021
NCT05159440CollaboratorPhase 1Dec 15, 2021
NCT05103683CollaboratorPhase 1Nov 15, 2021
NCT04553770CollaboratorPhase 2Oct 9, 2020
NCT04261218Lead sponsorPhase 1Feb 29, 2020
NCT03830918CollaboratorPhase 1/Phase 2Mar 6, 2019
NCT03701334CollaboratorPhase 3Dec 7, 2018
NCT03672773CollaboratorPhase 2Oct 1, 2018
NCT03004534Lead sponsorEarly Phase 1Jun 1, 2017
NCT03004534Study directorEarly Phase 1Jun 1, 2017

Details

Founded: Edmonton, CA Jan 1, 1997
Last known activity: Dec 4, 2023